newsfilter
← Latest News
GlobeNewswire·

GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) announced its support for the Sickle Cell Disease Treatment Centers Act of 2022, which was introduced today and, if passed in its curre